Download or read book Focus on Serotonin Uptake Inhibitor Research written by Anne C. Shirley and published by Nova Publishers. This book was released on 2006 with total page 244 pages. Available in PDF, EPUB and Kindle. Book excerpt: The most significant class of antidepressants marketed in recent years is the selective serotonin re-uptake inhibitors (SSRIs). Claims of decreased adverse effects (ADRs) and increased safety have led to extensive use of these drugs by non-psychiatrists. The six SSRIs available in the United States are citalopram (Celexa), escitalopram (Lexapro), fluoxetine (Prozac), fluvoxamine (Luvox), paroxetine (Paxil), and sertraline (Zoloft). The primary uses for the SSRIs include unipolar and bipolar major depression and all of the anxiety disorders. However, controlled trials also support the use of SSRIs in the treatment of other psychiatric disorders including dysthymia, pre-menstrual dysphoria, bulimia nervosa, obesity, borderline personality disorder, alcoholism, rheumatic pain, and migraine headache. This new book presents leading-edge research from throughout the world on this topic.
Download or read book Serotonin norepinephrine Reuptake Inhibitors Advances in Research and Application 2012 Edition written by and published by ScholarlyEditions. This book was released on 2012-12-26 with total page 38 pages. Available in PDF, EPUB and Kindle. Book excerpt: Serotonin-norepinephrine Reuptake Inhibitors—Advances in Research and Application: 2012 Edition is a ScholarlyPaper™ that delivers timely, authoritative, and intensively focused information about Serotonin-norepinephrine Reuptake Inhib in a compact format. The editors have built Serotonin-norepinephrine Reuptake Inhibitors—Advances in Research and Application: 2012 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Serotonin-norepinephrine Reuptake Inhib in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Serotonin-norepinephrine Reuptake Inhibitors—Advances in Research and Application: 2012 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.
Download or read book Selective Serotonin Reuptake Inhibitor New Insights for the Healthcare Professional 2012 Edition written by and published by ScholarlyEditions. This book was released on 2012-12-10 with total page 21 pages. Available in PDF, EPUB and Kindle. Book excerpt: Selective Serotonin Reuptake Inhibitor: New Insights for the Healthcare Professional / 2012 Edition is a ScholarlyPaper™ that delivers timely, authoritative, and intensively focused information about Selective Serotonin Reuptake Inhibitor in a compact format. The editors have built Selective Serotonin Reuptake Inhibitor: New Insights for the Healthcare Professional / 2012 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Selective Serotonin Reuptake Inhibitor in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Selective Serotonin Reuptake Inhibitor: New Insights for the Healthcare Professional / 2012 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.
Download or read book Selective Serotonin Reuptake Inhibitors Advances in Research and Application 2013 Edition written by and published by ScholarlyEditions. This book was released on 2013-06-21 with total page 44 pages. Available in PDF, EPUB and Kindle. Book excerpt: Selective Serotonin Reuptake Inhibitors—Advances in Research and Application: 2013 Edition is a ScholarlyPaper™ that delivers timely, authoritative, and intensively focused information about ZZZAdditional Research in a compact format. The editors have built Selective Serotonin Reuptake Inhibitors—Advances in Research and Application: 2013 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about ZZZAdditional Research in this book to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Selective Serotonin Reuptake Inhibitors—Advances in Research and Application: 2013 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.
Download or read book Electrochemical Methods for Neuroscience written by Adrian C. Michael and published by CRC Press. This book was released on 2006-12-13 with total page 540 pages. Available in PDF, EPUB and Kindle. Book excerpt: Since the first implant of a carbon microelectrode in a rat 35 years ago, there have been substantial advances in the sensitivity, selectivity and temporal resolution of electrochemical techniques. Today, these methods provide neurochemical information that is not accessible by other means. The growing recognition of the versatility of electrochemi
Download or read book Selective Serotonin Reuptake Inhibitors Advances in Research and Application 2012 Edition written by and published by ScholarlyEditions. This book was released on 2012-12-26 with total page 91 pages. Available in PDF, EPUB and Kindle. Book excerpt: Selective Serotonin Reuptake Inhibitors—Advances in Research and Application: 2012 Edition is a ScholarlyBrief™ that delivers timely, authoritative, comprehensive, and specialized information about Selective Serotonin Reuptake Inhibitors in a concise format. The editors have built Selective Serotonin Reuptake Inhibitors—Advances in Research and Application: 2012 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Selective Serotonin Reuptake Inhibitors in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Selective Serotonin Reuptake Inhibitors—Advances in Research and Application: 2012 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.
Download or read book Selective Serotonin Reuptake Inhibitors Advances in Research and Application 2011 Edition written by and published by ScholarlyEditions. This book was released on 2012-01-09 with total page 45 pages. Available in PDF, EPUB and Kindle. Book excerpt: Selective Serotonin Reuptake Inhibitors: Advances in Research and Application: 2011 Edition is a ScholarlyBrief™ that delivers timely, authoritative, comprehensive, and specialized information about Selective Serotonin Reuptake Inhibitors in a concise format. The editors have built Selective Serotonin Reuptake Inhibitors: Advances in Research and Application: 2011 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Selective Serotonin Reuptake Inhibitors in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Selective Serotonin Reuptake Inhibitors: Advances in Research and Application: 2011 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.
Download or read book Trends in Serotonin Uptake Inhibitor Research written by Anne C. Shirley and published by . This book was released on 2005 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: The most significant class of antidepressants marketed in recent years is the selective serotonin reuptake inhibitors (SSRIs). Claims of decreased adverse effects (ADRs) and increased safety have led to extensive use of these drugs by non-psychiatrists. The six SSRIs available in the United States are citalopram (Celexa), escitalopram (Lexapro), fluoxetine (Prozac), fluvoxamine (Luvox), paroxetine (Paxil), and sertraline (Zoloft). The primary uses for the SSRIs include unipolar and bipolar major depression and all of the anxiety disorders. However, controlled trials also support the use of SSRIs in the treatment of other psychiatric disorders including dysthymia, premenstrual dysphoria, bulimia nervosa, obesity, borderline personality disorder, alcoholism, rheumatic pain, and migraine headache. This new book presents leading-edge research from throughout the world on this.
Download or read book Selective Serotonin Re Uptake Inhibitors written by J. P. Feighner and published by Wiley. This book was released on 1996-06-19 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: Interest in Selective Serotonin Re-Uptake Inhibitors has grown considerably in recent years, particularly as their therapeutic profile is expanding to the treatment of other types of psychiatric disorder besides depression. It is therefore timely that the authors of Selective Serotonin Re-Uptake Inhibitors should now provide a second edition. Reorganised and updated to include additional chapters which greatly extend the scope of the book, this edition gives an excellent review of the biochemical, pharmacological and clinical aspects of this important group of drugs. Written by an array of outstanding, authoritative, international scientists and clinicians this invaluable reference provides a wealth of knowledge and an extensive source of up-to-date references on a subject that is important to every clinician involved in treating psychiatric patients as well as those carrying out research in this field.
Download or read book Selective Serotonin Re Uptake Inhibitors written by J. P. Feighner and published by . This book was released on 1991-05-13 with total page 176 pages. Available in PDF, EPUB and Kindle. Book excerpt: Based on research into paroxetine, fluoxetine, and other selective serotonin re-uptake inhibitors. The authors maintain that these drugs represent a significant addition in psychiatry because of their relative lack of side effects and broad range of clinical indications.
Download or read book Antidepressants Past Present and Future written by Renato D. Alarcón and published by Springer Science & Business Media. This book was released on 2004-02-19 with total page 644 pages. Available in PDF, EPUB and Kindle. Book excerpt: With contribution by numerous experts
Download or read book Selective Serotonin Reuptake Inhibitors SSRIs written by S. Clare Stanford and published by Landes Bioscience. This book was released on 1999 with total page 248 pages. Available in PDF, EPUB and Kindle. Book excerpt: Details advantages and disadvantages of SSRIs. Starts with a personal memoir of the discovery of the first SSRI, then looks at SSRIs from the clinical point of view. Later chapters concentrate on preclinical material. A final chapter makes pharmacological and clinical comparisons between the tricycl
Download or read book The Neurobiological Basis of Suicide written by Yogesh Dwivedi and published by CRC Press. This book was released on 2012-06-25 with total page 485 pages. Available in PDF, EPUB and Kindle. Book excerpt: With recent studies using genetic, epigenetic, and other molecular and neurochemical approaches, a new era has begun in understanding pathophysiology of suicide. Emerging evidence suggests that neurobiological factors are not only critical in providing potential risk factors but also provide a promising approach to develop more effective treatment and prevention strategies. The Neurobiological Basis of Suicide discusses the most recent findings in suicide neurobiology. Psychological, psychosocial, and cultural factors are important in determining the risk factors for suicide; however, they offer weak prediction and can be of little clinical use. Interestingly, cognitive characteristics are different among depressed suicidal and depressed nonsuicidal subjects, and could be involved in the development of suicidal behavior. The characterization of the neurobiological basis of suicide is in delineating the risk factors associated with suicide. The Neurobiological Basis of Suicide focuses on how and why these neurobiological factors are crucial in the pathogenic mechanisms of suicidal behavior and how these findings can be transformed into potential therapeutic applications.
Download or read book Serotonin Receptor Electrophysiology in Cortical Neurons Critical for the Response to Antidepressants written by Kristina Elice Perit and published by . This book was released on 2015 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: The gold standard for treating depression is a class of medicines known as selective serotonin reuptake inhibitors (SSRIs). Recent research identified a subgroup of layer V pyramidal neurons in the cerebral cortex important for the antidepressant action of SSRIs. Using transgenic mice that have these p11-expressing neurons labeled with GFP, I characterized these neurons and their neighbours under control conditions and after chronic treatment with the SSRI fluoxetine (FLX). Experiments were conducted with a particular focus on serotonin (5-HT) responses, using whole-cell recording in acute brain slices of motor and prefrontal cortex. Further investigation explored the effects of chronic FLX treatment in a mouse model of stress. I found that chronic FLX treatment has significant effects on neurons in both motor and prefrontal cortices, that p11-expressing neurons differ subtly in their response to 5-HT, and that there is evidence of an interaction between stress and FLX treatment in p11-expressing neurons.
Download or read book NeuroPsychopharmacotherapy written by Peter Riederer and published by Springer Nature. This book was released on 2022-11-04 with total page 4652 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book provides a reference guide describing the current status of medication in all major psychiatric and neurological indications, together with comparisons of pharmacological treatment strategies in clinical settings in Europe, USA, Japan and China. In addition, it highlights herbal medicine as used in China and Japan, as well as complementary medicine and nutritional aspects. This novel approach offers international readers a global approach in a single dedicated publication and is also a valuable resource for anyone interested in comparing treatments for psychiatric disorders in three different cultural areas. There are three volumes devoted to Basic Principles and General Aspects, offering a general overview of psychopharmacotherapy (Vol. 1); Classes, Drugs and Special Aspects covering the role of psychotropic drugs in the field of psychiatry and neurology (Vol. 2) and Applied Psychopharmacotherapy focusing on applied psychopharmacotherapy (Vol. 3). These books are invaluable to psychiatrists, neurologists, neuroscientists, medical practitioners and clinical psychologists.
Download or read book Stahl s Illustrated Antidepressants written by Stephen M. Stahl and published by Cambridge University Press. This book was released on 2009-03-02 with total page 199 pages. Available in PDF, EPUB and Kindle. Book excerpt: All of the titles in the Stahl's Illustrated Series are designed to be fun. Concepts are illustrated by full-color images that will be familiar to all readers of Stahl's Essential Psychopharmacology, 3rd Edition and The Prescriber's Guide. The texts in this user-friendly series can be supplements to figures, images, and tables. The visual learner will find that these books make psychopharmacology concepts easy to master, while the non-visual learner will enjoy a shortened text version of complex psychopharmacology concepts. Within each book, each chapter builds on previous chapters, synthesizing information from basic biology and diagnostics to building treatment plans and dealing with complications and comorbidities. Novices may want to approach Stahl's Illustrated Series by first looking through all the graphics and gaining a feel for the visual vocabulary. Readers more familiar with these topics should find that going back and forth between images and text provides an interaction with which to vividly conceptualize complex pharmacologies. And, to help guide the reader toward more in-depth learning about particular concepts, each book ends with a Suggested Reading section.
Download or read book Psychiatric Pharmacogenomics written by David Mrazek and published by Oxford University Press. This book was released on 2010-06-10 with total page 276 pages. Available in PDF, EPUB and Kindle. Book excerpt: Psychiatric Pharmacogenomics is a book written to help clinicians to use pharmacogenomic testing to improve the pharmacotherapy that they provide for their patients. It is designed to teach clinicians how to order pharmacogenomic tests and interpret the results. Clinical examples are used to underscore the specific indications for pharmacogenomic testing and to clarify the clinical usefulness of identifying atypical genotypes that result in problematic responses to medication. The first section of the book begins with a basic review of molecular genetics. Additionally, the book also includes an extensive glossary of technical terms associated with molecular genetics and pharmacogenomics. The clinical utility of pharmacogenomic testing is demonstrated throughout the book by describing the implications of genetic variations for the care of individual patients. The second section of the book is organized into fourteen chapters that each focus on the clinical implications of testing for specific genes for which variants have been associated with either therapeutic response or side effects of psychotropic medications. Each of these chapters is structured in the same manner and involves a description of the gene and its significant variants. Each chapter also includes one or more clinical vignettes. The third section of the book discusses the clinical usefulness of pharmacogenomic testing, ethical issues associated with pharmacogenomic testing, and provides predictions for the future development of more sophisticated pharmacogenomic testing.
